Mercaptopurine/Methotrexate/Prednisone/Vincristine Alternating with Blinatumomab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of mercaptopurine, vincristine, methotrexate, and prednisone, alternating with blinatumomab, that may be used in the treatment of acute lymphoblastic leukemia (ALL).

**Synonyms:** - Mercaptopurine/Vincristine/Methotrexate/Prednisone Alternating with Blinatumomab Regimen - POMP Alternating with Blinatumomab Regimen - Purinethol/Oncovin/Methotrexate/Prednisone Alternating with Blinatumomab Regimen